Tuberculosis in Thailand: epidemiology and program performance, 2001–2005  by Jittimanee, Suksont et al.
Tuberculosis in Thailand: epidemiology and program
performance, 2001—2005§
Suksont Jittimanee a, Jirawat Vorasingha a, Wiriya Mad-asin a,
Sriprapa Nateniyom a, Somsak Rienthong a, Jay K. Varma b,c,*
aThailand Ministry of Public Health, Nonthaburi, Thailand
bUS Centers for Disease Control and Prevention, Atlanta, Georgia, USA
cThailand MOPH—US CDC Collaboration, Nonthaburi, Thailand
Received 5 June 2008; received in revised form 2 July 2008; accepted 15 July 2008
Corresponding Editor: William Cameron, Ottawa, Canada
International Journal of Infectious Diseases (2009) 13, 436—442
http://intl.elsevierhealth.com/journals/ijid
KEYWORDS
Tuberculosis;
Mortality;
Thailand;
Surveillance;
HIV/AIDS;
DOTS
Summary
Background: The World Health Organization (WHO) recommends a package of services branded
‘DOTS’ (directly observed treatment, short course) to help countries detect at least 70% of all
infectious tuberculosis (TB) cases and cure 85% of detected cases. We analyzed the epidemiology
of TB and the national TB program (NTP) performance for the first 5 years of DOTS implementation
in Thailand.
Methods: We reviewed data routinely collected through the NTP from 2001 to 2005 and data from
special projects conducted by the NTP from 2001 to 2006.
Results: In 2005, the TB notification rate was 94 per 100 000 persons. Using the WHO estimated
incidence as the denominator, the case detection rate was 76% for smear-positive cases in 2005.
From 2002 to 2005, the notification rate declined 2% for smear-positive cases. In 2005, 68% of
smear-positive patients were successfully treated; from 2001 to 2005, treatment success never
exceeded 75%. Separate surveys conducted from 2002 to 2006 found that 13—17% of TB cases
were HIV-infected. The estimated prevalence of multidrug-resistant TB in new patients increased
from 1% in 2002 to 1.7% in 2006.
Conclusions: Since DOTS implementation, Thailand has exceeded the international TB case
detection target, but has remained well below the treatment success target. The large dis-
crepancy between case finding and treatment success rates indicates that actions are urgently
needed to reduce TB morbidity and prevent drug-resistant TB.
Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.§ The findings and conclusions in this report are those of the
authors and do not necessarily represent the views of US CDC.
* Corresponding author. CDC, U.S. Embassy Beijing No. 3, Xiu Shui
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Since the early 1990s, global tuberculosis (TB) control
efforts have focused most intensely on 22 countries that
together comprise 80% of the world’s TB cases.1 Thailand,Society for Infectious Diseases.
Tuberculosis in Thailand, 2001—2005 437a middle-income country in Southeast Asia, ranks 17th on this
list of 22 ‘high-burden’ TB countries, with an estimated
91 374 new TB cases occurring in 2005.2 Although case noti-
fications declined in Thailand throughout most of the 20th
century, notifications began rising in the 1990s co-incident
with an explosive epidemic of HIV.3 In 1996, Thailand offi-
cially adopted the internationally-recommended TB control
strategy known as DOTS (directly observed treatment, short
course), which includes a package of policies and practices to
detect and cure TB patients, particularly those who are most
infectious. After initial piloting of the strategy at selected
sites, Thailand declared in 2001 that at least one public
healthcare facility implementing DOTS had been established
in all districts.
Epidemiologic models of TB control predict that countries
that achieve high-levels of TB program performance will see
substantial reductions in TB incidence, prevalence, and mor-
tality.1 The main targets for TB program performance are
case detection and treatment success; countries that detect
70% of all estimated TB cases and successfully treat 85% of
detected, acid-fast bacilli smear-positive pulmonary TB
cases should expect declines in incidence of 8—12% per year.4
In 2003, a review conducted jointly by the World Health
Organization (WHO) and the Thailand Ministry of Public
Health (MOPH) highlighted several challenges to TB control
in Thailand, including high rates of death and default and the
need for more intensive supervision, training, andmonitoring
of TB control at all levels of the health system.5
Relying on data collected routinely and from special
government projects, we analyzed the epidemiology of TB
and the national TB program performance from 2001 to 2005
to assess the magnitude and characteristics of the TB epi-
demic and to identify barriers to program success.
Methods
Public healthcare system
Thailand consists of 75 provinces and the autonomous muni-
cipal area of Bangkok, the capital city. Outside of Bangkok,
provinces are divided into districts. Each district has at least
one government hospital, which serves as the basic manage-
ment unit for TB control, performing sputum smear-micro-
scopy to diagnose TB, maintaining the TB register, and
supervising treatment. Provinces also have at least one
provincial hospital that serves as a referral center for spe-
cialized clinical services and can also serve as a basic man-
agement unit for TB. In Bangkok, public health services are
provided through district health centers and nine large public
hospitals, all of which serve as basic management units for TB
control. Persons may also be diagnosed with TB at other
healthcare facilities, including those operated by the gov-
ernment (e.g., military, police), those partially supported by
the government (e.g., universities), and those operated by
private entities. Such additional healthcare services are
widely available in Bangkok and some other cities, but less
so in most provinces. Health facilities are legally required to
report TB cases to public health agencies, but in practice this
is not enforced. No laws prevent pharmacies or healthcare
facilities from selling anti-TB drugs.
Consistent with international standards, TB diagnosis is
made primarily based on sputum smear microscopy and isprovided free to patients. Many large, public hospitals can
perform mycobacterial culture, but do so infrequently; most
physicians only request mycobacterial culture for patients
suspected of having drug-resistant TB.
National recording and reporting system for TB
control, 2001—2005
Sources of reporting
Outside of Bangkok, basic management units for TB sent
standardized summary reports to provincial public health
offices every four months. These provincial offices prepared
aggregate paper-based reports,whichwere then forwarded to
the MOPH. Reports were compiled by the national TB program
(NTP). Aggregate reports were also received from 138 prisons
and from Bangkok health centers and hospitals. A small num-
ber of private, military, university, and non-government orga-
nization (NGO) health facilities sent reports either through
MOPH provincial public health offices or directly to the NTP.
The number of these non-MOPH facilities sending reports
varied annually and may have represented only a small pro-
portion of the non-MOPH facilities that treated TB patients.
Types of reports
Three reports were sent to the NTP: case detection, sputum
smear conversion, and treatment outcome. Each report
included a cohort of patients, i.e., a group of patients
registered for TB treatment during an identical four-month
period (e.g., 1 October 2001—31 January 2002). A ‘year’
corresponded to a fiscal year, which began on 1 October
and ended 30 September. Reports classified patients using
standard WHO TB program definitions.6 For example,
patients were classified by type of TB disease into smear-
positive, pulmonary smear-negative, and extrapulmonary
(EP). Patients were further classified by previous TB treat-
ment history into new, relapse, treatment after default,
treatment after failure, and other, using WHO definitions.
When reporting case detection data, relapse patients were
included as a separate type of TB disease, since such patients
are defined as smear-positive patients who had previously
been cured or had completed TB treatment. Treatment out-
comes were recorded as one of six, mutually exclusive
categories: cured, completed, died, defaulted, failed, and
transferred-out. ‘Successful’ outcomes comprise ‘cured’ plus
‘completed’ outcomes. If the count of cases in the case
detection report did not match the count of cases in the
treatment outcome report, the difference in cases was
reported as ‘not documented’.
Other TB-related data sources
We analyzed data from the MOPH vital registration system,
which classifies deaths recorded on death certificates accord-
ing to the International Classification of Diseases, 10th edi-
tion (ICD-10) codes. We used published and unpublished
reports from special MOPH projects involving drug-resistance
surveillance and HIV surveillance in TB patients. We included
reports of special studies conducted in 2006 when data from
2001 to 2005 were limited. Drug-resistance surveys used
internationally-recommended protocols for sampling new
and previously-treated smear-positive patients from public
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went culture and drug-susceptibility testing at the Thai
national TB reference laboratory, with quality assurance
from the WHO supranational reference laboratory in Korea.
For national estimates of the incidence and prevalence of TB
in 2005, we used data from WHO.2
Data sources not related to TB
For overall national population estimates, we used data from
the national census. For analyses according to age and/or
sex, we used end-of-year population data from theMinistry of
Interior (MOI). The total population estimated by these two
systems is different, with approximately 3 million persons
less counted in the MOI system; populations not counted in
the MOI system include migrant and non-Thai populations.
The MOI data, however, is believed to provide more accurate
estimations when populations are stratified by age and sex.
To stratify provinces by the prevalence of HIV infection,
we used data from the MOPH’s perinatal HIV monitoring
system, which collects data from routine HIV counseling
and testing of women who receive antenatal care or give
birth in MOPH hospitals.8 Although the prevalence of HIV in
pregnant women declined in Thailand from 2001 to 2005, we
chose to stratify provinces according to HIV prevalence in
2001, because we believed that incidence andmortality of TB
during the study period was unlikely to be altered signifi-
cantly over this period based on modest reductions in HIV
prevalence. We categorized provinces as ‘high’ HIV preva-
lence if the rate of HIV in pregnant women was 1% or more
and as ‘low’ HIV prevalence if the rate was less than 1% in
2001.
Data analysis
NTP surveillance data were compiled into an SQL database
and exported for analysis to Microsoft Excel. Population
denominators from the census were used to calculate
national notification rates. Denominators from the MOI were
used to calculate notification rates according to age and sex.
Analyses stratified by province and/or HIV prevalence
excluded data from prisoners, because the population inside
the prison was not necessarily derived from the province in
which the prison was located. Data from prisoners were used,
however, in calculating treatment outcomes at the national
level. In analyses that calculated rates according to HIV
prevalence in provinces, we calculated rates including andTable 1 Number and rate per 100 000 persons of TB case notific
TB patient type Number of cases (number per 100 000) a
2001 2002 2003
Pulmonary 44 737 (72) 52 283 (84) 51 59
Smear-positive 25 948 (42) 30 607 (49) 30 67
Smear-negative 17 137 (28) 19 858 (32) 19 10
Relapse 1652 (3) 1818 (3) 182
Extrapulmonary 5021 (8) 6855 (11) 730
Total 49 758 (80) 59 138 (95) 58 90
a Population denominator derived from census.excluding Bangkok, because the TB case notification rate in
Bangkok was substantially lower than the national rate and
the population denominator large. Statistical tests of sig-
nificance were not performed, because the source data were
national public health surveillance, not a random sample of
the population.
Human subjects
The US Centers for Disease Control and Prevention and the
Thai MOPH determined that this project was public health
program evaluation and not human subjects research requir-
ing institutional review board review.
Results
Case detection
In 2005, 58 691 TB cases were notified for an overall case
notification rate of 94 per 100 000 persons (Table 1). The
notification rate for smear-positive cases was 48 per 100 000
persons. Using the WHO estimated incidence (142 all cases
and 63 smear-positive cases per 100 000) as the denominator,
the case detection rate was 66% for all cases and 76% for
smear-positive cases in 2005. A marked increase in case
notifications occurred from 2001 to 2002, during which time
the proportion of districts reporting cases increased 2%. From
2002 to 2005, notifications per 100 000 persons declined 1%
for all cases and 2% for smear-positive cases. From 2001 to
2005, the proportion of cases that were smear-positive also
remained essentially stable, with 52% of cases reported being
smear-positive, 33% smear-negative, 3% relapse (smear-posi-
tive), and 12% EP.
In 2005, the notification rate per 100 000 was highest in
men and increased with age, with the highest case notifica-
tion rates found in men aged more than 65 years (177 per
100 000). The discrepancy between men and women
appeared in persons aged more than 15 years and was most
marked in persons aged 35—44 years, in which the notifica-
tion rate for men in 2005 was 3.7 times greater than that for
women (Figure 1).
Treatment outcomes
In 2005, the NTP was notified about treatment outcomes
for 51 060 TB patients, including 30 109 new, pulmonaryations in Thailand, 2001—2005.
Total No. (%)
2004 2005
9 (82) 51 471 (82) 51 060 (82) 251 150 (88%)
0 (49) 30 472 (49) 30 109 (48) 147 806 (52%)
6 (30) 19 168 (31) 19 167 (31) 94 436 (33%)
3 (3) 1831 (3) 1784 (3) 8908 (3%)
8 (12) 7868 (13) 7631 (12) 34 683 (12%)
7 (94) 59 339 (95) 58 691 (94) 285 833
Figure 1 Pulmonary, smear-positive case notification rate per
100 000 persons stratified by standard age categories and sex–—
Thailand, 2005.
Figure 2 Proportion of registered TB patients successfully
treated, stratified by type of TB–—Thailand, 2001—2005.
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positive patients, however, had treatment outcomes not
documented. Including these patients in the denominator,
the overall treatment success rate for smear-positive
patients was 68%. Of the 4717 patients with documented
unsuccessful outcomes (e.g., failure, death, and default),
2268 (48%) died, 1920 (41%) defaulted, and 529 (11%) failed
treatment. In patients with smear-negative TB, treatment
outcomes were similarly poor, with a large proportion of
patients without documented outcomes and with death
accounting for 52% of the 3571 patients with documented
unsuccessful outcomes. Since 2001, the overall treatment
success rate for smear-positive patients has fluctuated, but
remained less than 75% for all years (Figure 2). A decline in
treatment success rate in 2005 was caused by an increase in
the proportion of patients without documentation of treat-
ment outcome.
Regional differences in case detection and
treatment outcomes
Selected provinces had smear-positive notification rates
exceeding 70 per 100 000, while a large number of provinces,
including Bangkok, had rates less than 50 smear-positive
cases per 100 000 (Figure 3). Treatment success rates were
consistently highest in the northeastern region (Figure 4). In
southern and northern provinces, low treatment successTable 2 Treatment outcomes for registered TB patients, stratifi
Type of TB
patient
No.
Registered
Treatment outcome, N (% of regi
Cured Completed Fa
New, pulmonary
smear-positive
30 109 18 925 (62.9) 1404 (4.7) 52
New, pulmonary
smear-negative
19 167 N/A 11 452 (59.7) 7
Relapse 1784 803 (45.0) 98 (5.5) 6
Treatment after
failure
N/A 242 (52.7) 25 (5.4) 4
N/A, not available or not applicable.rates were attributable to high rates of death, which
exceeded 16% in some provinces. Default rates exceeded
16% in some provinces, most notably one large province on
the Thai—Myanmar border.
TB deaths
In 2005, the death rate during TB treatment was highest in
patients who were being re-treated, either as relapses or as
failures of first-line treatment (Table 2). The MOPH vital
registration system recorded 5534 deaths attributable to
TB (all forms) in 2005. This compares with only 4371 deaths
recorded through the NTP for the same year. Using vital
registration data, the estimated TB mortality rate was 9
per 100 000, and 1.4% of all deaths in Thailand were attri-
butable to TB. The rate of death from TB was more than two
times higher in men (13 per 100000) than in women (5 per
100 000). Also, 1.7% of all deaths in men were attributable to
TB compared with only 0.9% in women. Of the 5534 deaths,
most occurred in persons 65 years and older (n = 1496; 27%)
and in persons aged 35—44 years (n = 1187; 21%).ed by type of TB–—Thailand, 2005.
stered)
iled Died Defaulted Transferred
out
Not
evaluated
9 (1.8) 2268 (7.5) 1920 (6.4) 742 (2.5) 4321 (14.3)
8 (0.4) 1843 (9.6) 1650 (8.6) 581 (3.0) 3563 (18.6)
4 (3.6) 195 (10.9) 105 (5.9) 57 (3.2) 462 (25.9)
0 (8.7) 65 (14.2) 54 (11.8) 33 (7.2) N/A
Figure 3 Notification rate per 100 000 persons of smear-posi-
tive (M+) pulmonary TB cases–—Thailand, 2005.
Figure 4 Proportion of TB cases successfully treated among all
cases that were registered for TB treatment–—Thailand, 2005.
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Of 30 109 smear-positive TB cases notified to the TB program
in 2005, only 116 (0.4%) were in children (age <15 years). A
similar calculation was not available for all TB cases, because
age group is only collected for smear-positive cases. Of cases
notified, 19% were from northern Thailand. The notification
rate for smear-positive cases was unchanged from 2001 to
2005, remaining at 1 per 100 000 children. Treatment success
data stratified by age group were not available.
HIV-associated TB
Although theWHO estimated that 7.6% of incident TB cases in
persons aged 15—49 were HIV-infected in 2005, special MOPH
projects conducted from 2002 to 2006 found higher rates.2 In
2002, TB patients were included in annual HIV sentinel
surveillance efforts; 129 (13%) of 986 TB patients (all forms)
from 12 TB regional referral centers were found to be HIV-infected. In 2005, 1389 (24%) of 5832 TB patients were found
to be HIV-infected in a four-province TB/HIV surveillance
project, with rates varying from 15% in two provinces in the
central and northeast regions of Thailand to 26% in one
southern and 34% in one northern province. In 2006, another
MOPH project found that 185 (17%) of 1086 new adult TB
patients were HIV-infected in 12 large public hospitals in all
regions of Thailand.
In 2005, the notification rate for TB was 98 per 100 000
persons in the 53 high HIV prevalence provinces and 91 per
100 000 in the 22 low HIV prevalence provinces. Compared
with 2002, the notification rate for TB declined 5% in low HIV
prevalence provinces compared with an increase of 2% in high
HIV prevalence provinces (Figure 5). For individual cases,
treatment outcomes stratified by HIV status were not avail-
able. For provinces, treatment outcome rates were consis-
tently lower in high HIV prevalence provinces compared with
low HIV prevalence provinces. Among patients with docu-
mented outcomes in low HIV prevalence provinces, the
Figure 5 Overall and pulmonary, smear-positive (M+) case
notification rate per 100 000, stratified by high and low HIV
prevalence provinces. High HIV prevalence was defined as HIV
prevalence in pregnant women 1%. Bangkok is excluded in this
analysis, because of low TB notification rates (numerator incor-
rectly small) and high population (denominator large).
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and default 13%; in high HIV prevalence provinces, the
success rate was 76% and the combined rate of death and
default 18%.
Drug-resistant TB
One national drug-resistance survey was conducted from
2001 to 2005. Results from this survey in 2002 found that
the rate of MDR-TB was 1% in 1505 new TB patients and 20% in
172 previously treated patients. In new patients, resistance
to at least isoniazid was found in 9.5% and to rifampin in 1.4%.
A second drug-resistance survey initiated in 2006 found that
the rate of MDR-TB had increased to 1.7% in 1150 new TB
patients and 34.5% in 194 previously treated patients. In new
patients, resistance to at least isoniazid was found in 9.7%;
resistance to rifampin had increased to 2.6%. Data on HIV
status of patients were not collected.
Discussion
Since nationwide implementation of DOTS in 2001, Thailand
has achieved the international TB case detection target, but
has remained well below the treatment success target from
2001 to 2005. Epidemiologic models predict that the NTP will
not substantially reduce the burden of TB until the WHO
target of 85% treatment success is achieved.4 TB notification
rates can be used as an indicator of national trends in the
burden of disease, if such systems have sufficient coverage,
completeness, and quality.9 In Thailand, the overall coverage
of reporting units (as measured by the smear-positive case
detection rate of 76% in 2005) and intensity of case finding (as
measured by the stable proportion of cases that were smear-
positive) has likely been sufficient enough since 2002 to
monitor trends in disease burden. The large increase in casereporting from 2001 to 2002 suggests that reporting during
the first year of nationwide DOTS implementation was still
incomplete. From 2002 to 2005, the notification rate
declined slightly (1% for all cases, 2% for smear-positive),
but rose slightly in HIV-prevalent provinces; these small
changes likely represent a stable burden of TB across Thai-
land. Of particular concern is the combination of a high case
detection rate and low treatment success rate, a major risk
factor for the emergence and dissemination of drug-resistant
TB.10 This situation could be occurring in Thailand, as demon-
strated by the near doubling in the MDR-TB rate from 2002 to
2006.
Treatment success rates were low because of the large
proportion of cases that did not have documented treatment
outcomes, that defaulted, and that died. When calculating
success rates, the NTP uses the aggregate number of cases
registered as its denominator; if the case finding report has a
larger number of cases than those reported on the corre-
sponding treatment outcome report, which may arrive up to
one year after the case finding report, then the difference is
reported as ‘not documented’. Why the proportion of persons
‘not documented’ was so high needs to be systematically
evaluated, and the discrepancy corrected in order to have
reliable monitoring of treatment outcomes.
Reducing default and death rates may be more challen-
ging. Program experience indicates that many different
groups are at high risk for both default and death, including
migrants, the elderly, and HIV-infected persons. Most TB
treatment facilities in Thailand do not provide intensive case
management services; TB services usually consist of basic
health education at the beginning of treatment and drug
administration during treatment. Most patients receive
‘family’ directly observed therapy (DOT) which, in actual
practice, may be a self-administered treatment.11 Efforts are
urgently needed to identify evidence-based methods to
reduce default, potentially through more intensive counsel-
ing and treatment supervision.12 A major contributor to the
high death rate is HIV-associated TB, which has a case-fatality
rate exceeding 20% in Thailand and other Southeast Asian
countries.13—15 Epidemiologic studies have documented that
providing anti-retroviral therapy to HIV-infected TB patients
can reducemortality considerably in Thailand.13,16 Both anti-
TB therapy and anti-retroviral therapy are free and widely
available, without supply interruptions, in public hospitals
through the government’s national health insurance plan.
A major limitation to our study is that several populations
are known to be under-represented in NTP data. First, case
notification rates in Bangkok are less than half the national
rate (data not shown), which is thought to be due to the large
number of private, university, and other government health
facilities that treat but do not report TB cases. Efforts are
underway to strengthen reporting in Bangkok.17 Second, few
cases of childhood TB were reported, potentially due to
under-diagnosis, under-reporting, and/or the international
practice of only recording age categories for smear-positive
cases, even though most childhood TB cases are not smear-
positive. Third, a large number of non-Thai patients live in
Thailand, most of whom are economic migrants from neigh-
boring, high-burden TB countries.18 From 2001 to 2005, some
districts included non-Thai patients in their routine program
reporting, while others did not. A separate reporting form
for non-Thais has since been implemented. Fourth, formal
442 S. Jittimanee et al.evaluations of local reporting practices are needed, because
it is possible that program data were not accurately
recorded.
Perhaps the biggest limitation of this study is that the
precise burden of TB in Thailand is unknown. The last high-
quality, national survey of TB prevalence was conducted in
1991 and, since then, the dynamic of the epidemic, parti-
cularly because of HIV, has likely changed substantially.9 The
case detection rate that we report is based on the WHO
estimate, which is based, in part, on national surveillance
data, potentially leading to compounding of errors when the
two numbers are used to calculate the case detection rate.
Measuring the precise magnitude of the TB epidemic would
greatly improve our understanding of Thailand’s progress
toward TB control and help identify how much, if any,
investment should be placed on improving case detection.
For now, the large discrepancy between the case finding rate
and treatment success rate indicates that intensified pro-
grammonitoring and case management are urgently needed.
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